Navin Fluorine International (532504) Q1 24/25 earnings summary

Executive summary

• Achieved consolidated revenue of INR 524 crore in Q1 FY25, up 7% year-over-year, driven by strong HPP performance and new R-32 capacity sales, but operating EBITDA declined 12% to INR 100 crore and PAT fell 17% to INR 51.2 crore due to margin pressures.

• Specialty chemicals and CDMO segments faced headwinds from global inventory rationalization and delayed purchasing decisions.

• Multiple capacity expansion projects are progressing on schedule, with significant CapEx investments in agro, AHF, cGMP4, and R-32 plants.

• Leadership transition with a new Managing Director, bringing extensive industry experience.

• The group includes several subsidiaries and a joint venture, with the chemical business as the sole reportable segment.

Financial highlights

• Q1 FY25 consolidated revenue reached INR 524 crore, up 7% year-over-year; standalone revenue was INR 376.28 crore, up 7% year-over-year.

• Operating EBITDA was INR 100 crore, down 12% year-over-year, with margins at 19.2% versus 23.3% last year.

• Profit after tax stood at INR 51.2 crore, a 17% decline year-over-year, mainly due to higher depreciation from new CapEx.

• Operating cash flow for the quarter was INR 107 crore, supported by improved working capital management.

• Net debt to equity at 0.38x as of June 2024.

Outlook and guidance

• Expect gradual margin improvement through FY25, with a stronger second half anticipated for both specialty and CDMO segments.

• Firm orders secured for new agro specialty capacity, with commercial production set for September.

• CDMO business expected to surpass FY24 performance, with a $100 million revenue aspiration by FY27.

• Peak revenue guidance for new INR 540 crore CapEx remains unchanged, targeting full ramp-up by FY27.

• CapEx projects on track: INR 450 crore AHF plant to commission by end FY25/early FY26; INR 84 crore R-32 capacity expansion to be commissioned by Feb 2025; cGMP4 CapEx of INR 288 crore for CDMO business to be commissioned by end CY2025.